ACL (group 1A) (n = 118) | Controls (n = 260) | ACL (group 1A) (n = 118) | Controls | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allele | n | F % | n | F % | P -value | P c-value | OR | 95%CI | Allele | n | F % | n | F % | P -value | P c-value | OR | 95%CI |
HLA – A* | HLA-B* | ||||||||||||||||
01 | 26 | 11.0 | 47 | 9.0 | ns | - | 07 | 14 | 5.9 | 38 | 7.3 | ns | - | ||||
02 | 64 | 27.1 | 127 | 24.4 | ns | - | 08 | 10 | 4.2 | 34 | 6.5 | ns | - | ||||
03 | 21 | 8.9 | 56 | 10.8 | ns | - | 14 | 10 | 4.2 | 22 | 4.2 | ns | - | ||||
11 | 16 | 6.8 | 26 | 5.0 | ns | - | 15 | 22 | 9.3 | 48 | 9.2 | ns | - | ||||
24 | 24 | 10.2 | 62 | 11.9 | ns | - | 18 | 10 | 4.2 | 36 | 6.9 | ns | - | ||||
HLA-DRB1* | 27 | 3 | 1.3 | 8 | 1.5 | ns | - | ||||||||||
01 | 16 | 6.8 | 42 | 8.1 | ns | 35 | 44 | 18.6 | 68 | 13.1 | ns | - | |||||
03 | 20 | 8.4 | 61 | 11.7 | ns | - | 39 | 8 | 3.4 | 18 | 3.5 | ns | - | ||||
04 | 27 | 11.4 | 56 | 10.8 | ns | - | 40 | 12 | 5.1 | 16 | 3.1 | ns | - | ||||
07 | 29 | 12.3 | 67 | 12.9 | ns | - | 44 | 35 | 14.8 | 46 | 8.9 | 0.0160 | 0.4969 | 1.79 | 1.12-2.87 | ||
08 | 17 | 7.2 | 30 | 5.8 | ns | - | 45 | 0 | - | 12 | 2.3 | 0.0231 | 0.0225 | - | - | ||
11 | 31 | 13.1 | 81 | 15.6 | ns | - | 49 | 3 | 1.3 | 8 | 1.5 | ns | - | ||||
13 | 38 | 16.1 | 54 | 10.4 | 0.0152 | 0.2280 | 1.65 | 1.06-2.59 | 51 | 20 | 8.5 | 44 | 8.5 | ns | - | ||
14 | 11 | 4.7 | 40 | 7.7 | ns | 52 | 6 | 2.5 | 11 | 2.1 | ns | - | |||||
15 | 24 | 10.2 | 44 | 8.8 | ns | - |